Health In Tech, Inc. Class A (HIT) AI Stock Analysis

• Market Cap: $9.36M
• Dividend Yield: N/A
• Average Volume (3M): 306.68K
• Price to Earnings (P/E): 57.0
• Beta (1Y): 1.37
• Revenue Growth: 11.25%
• EPS Growth: -40.66%
• Country: US
• Employees: N/A
• Sector: Technology
• Sector Strength: 94
• Industry: Software
• EPS (TTM): 0.01
• Shares Outstanding: 42,973,206
• 10 Day Avg. Volume: 330,431
• 30 Day Avg. Volume: 306,677
• PEG Ratio: 0.56
• Price to Book (P/B): 2.43
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 13.16
• Enterprise Value/Market Cap: 2.89
• Enterprise Value/Revenue: 0.35
• Enterprise Value/Gross Profit: 1.62
• Enterprise Value/Ebitda: 2.63
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 70 Outperform
• Price Target: $1.00 ▲(42.86%Upside)

The overall stock score for Health In Tech, Inc. is driven primarily by strong financial performance and favorable earnings call insights. However, technical indicators suggest caution due to overbought conditions, and the valuation appears stretched given the high P/E ratio and lack of dividends. Operational inefficiencies and increased expenses also temper the outlook.

Health In Tech, Inc. Class A Business Overview & Revenue Model

Company Description

Health In Tech, Inc. Class A (HIT) is a technology-driven company operating within the healthcare sector. It specializes in providing innovative health insurance technology solutions designed to streamline the processes of insurance brokers and carriers. The company's core products and services include advanced software platforms that facilitate seamless management of health insurance plans, enrollment, billing, and claims processing. HIT focuses on delivering efficient, user-friendly solutions to enhance the overall experience for both insurers and policyholders.

How the Company Makes Money

Health In Tech, Inc. generates revenue primarily through the sale and subscription of its proprietary software platforms to insurance brokers, carriers, and other stakeholders in the healthcare insurance industry. The company's key revenue streams include software licensing fees, subscription-based models for continued access to their platforms, and consulting services related to the integration and optimization of their technology solutions. Additionally, HIT may earn income from strategic partnerships with other technology providers and insurance companies, which can lead to joint ventures or co-branded offerings that expand their market reach and customer base.

Health In Tech, Inc. Class A Financial Statement Overview

Summary

Health In Tech, Inc. shows strong revenue growth and a solid balance sheet with low leverage. However, declining profitability margins and reduced return on equity indicate potential operational inefficiencies. Cash flow generation is robust, though there is a need to enhance earnings quality to sustain long-term growth.

Income Statement

Health In Tech, Inc. has demonstrated significant revenue growth, increasing from $5.77 million in 2022 to $19.49 million in 2024. The company's gross profit margin is strong at approximately 79.2%, although the net profit margin has declined from 12.9% to 3.4% over the same period. The EBIT and EBITDA margins also show a downward trend, indicating potential challenges in controlling operating expenses.

Balance Sheet

The balance sheet reflects a robust equity position, with a high equity ratio of around 83.5%. The debt-to-equity ratio is low at 0.02, highlighting a conservative leverage approach. Return on equity has decreased from 40.6% in 2023 to 5.1% in 2024, suggesting a need for improved profitability.

Cash Flow

Operating cash flow has improved, and free cash flow increased significantly by 232% from 2023 to 2024. However, the operating cash flow to net income ratio decreased, indicating that cash generation relative to net profits has weakened. The company maintains a solid free cash flow to net income ratio, ensuring free cash flow remains healthy.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022
Income Statement
Total Revenue	22.38M	19.49M	19.15M	5.77M
Gross Profit	16.66M	15.44M	16.85M	5.44M
EBITDA	2.05M	1.93M	3.76M	205.58K
Net Income	1.07M	670.48K	2.48M	79.74K
Balance Sheet
Total Assets	11.50M	15.77M	11.50M	28.56M
Cash, Cash Equivalents and Short-Term Investments	2.42M	7.85M	2.42M	1.49M
Total Debt	1.92M	206.69K	1.92M	316.09K
Total Liabilities	5.41M	2.60M	5.41M	27.14M
Stockholders Equity	6.09M	13.17M	6.09M	1.05M
Cash Flow
Free Cash Flow	2.62M	1.28M	384.52K	-436.63K
Operating Cash Flow	3.38M	2.18M	1.53M	782.75K
Investing Cash Flow	-1.41M	-836.75K	-1.94M	-1.22M
Financing Cash Flow	4.24M	4.09M	1.34M	1.88M

Health In Tech, Inc. Class A Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HIT	70 Outperform	$9.36M	56.99	10.50%	―	11.25%	-40.66%
VERB	66 Neutral	$12.38M	―	-66.08%	―	3125.00%	98.06%
Sector *	63 Neutral	$34.16B	5.47	-11.67%	1.85%	5.30%	-18.30%
HKIT	48 Neutral	$41.31M	32.63	-2.82%	―	-36.35%	-153.77%
VS	39 Underperform	$12.70M	―	-34.07%	―	-78.87%	85.62%

Health In Tech, Inc. Class A Corporate Events

Health In Tech Board Restructures After Liang Resignation

On April 12, 2025, Lynn Liang announced her resignation from the Board of Directors of Health In Tech, Inc., effective April 18, 2025, due to other professional and personal commitments. Subsequently, on April 16, 2025, the Board decided to reduce its size from seven to six directors, also effective April 18, 2025.